McGregor M
Department of Medicine, McGill University Montreal, Québec.
Can J Cardiol. 1992 Sep;8(7):697-701.
To provide decision makers with a synthesis of the relevant information concerning the safety of pacemaker reuse, the ethical and legal issues which it raises and the extent of financial savings which may result.
Medline data bank and the bibliographies of review articles in English concerning refurbishment and reuse of cardiac pacemakers published up to June 1991.
Since 1978, reports of safe reuse of pacemakers have appeared in 11 countries. By 1984, review of nearly 2000 installations had produced no evidence of increased mortality or morbidity. The norms which must be respected to ensure safety are now well-known. The savings that might result from reuse can only be approximated. In Canada in 1989, 8684 pacemakers were installed. Assuming that 20% might be available for reuse, this practice might save approximately $4,000,000 per year to the Canadian health care system.
Properly carried out, pacemakers can be reused at an acceptably low risk. Any institution contemplating pacemaker reuse should define and approve appropriate guidelines and protocols governing the process. A registry to document the reuse of pacemakers for the next few years is desirable.
为决策者综合提供有关起搏器再利用的安全性、所引发的伦理和法律问题以及可能产生的资金节省程度的相关信息。
医学在线数据库以及截至1991年6月发表的有关心脏起搏器翻新和再利用的英文综述文章的参考文献。
自1978年以来,11个国家都出现了起搏器安全再利用的报告。到1984年,对近2000例植入病例的回顾未发现死亡率或发病率增加的证据。确保安全必须遵守的规范现已为人熟知。再利用可能产生的节省金额只能大致估算。1989年在加拿大,共植入了8684台起搏器。假设其中20%可用于再利用,这种做法每年可为加拿大医疗保健系统节省约400万美元。
如果操作得当,起搏器再利用的风险可以控制在可接受的低水平。任何考虑进行起搏器再利用的机构都应制定并批准有关该过程的适当指导方针和规程。建立一个登记处来记录未来几年起搏器的再利用情况是很有必要的。